HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Functional effects of the hypertrophic cardiomyopathy R403Q mutation are different in an alpha- or beta-myosin heavy chain backbone.

Abstract
The R403Q mutation in the beta-myosin heavy chain (MHC) was the first mutation to be linked to familial hypertrophic cardiomyopathy (FHC), a primary disease of heart muscle. The initial studies with R403Q myosin, isolated from biopsies of patients, showed a large decrease in myosin motor function, leading to the hypothesis that hypertrophy was a compensatory response. The introduction of the mouse model for FHC (the mouse expresses predominantly alpha-MHC as opposed to the beta-isoform in larger mammals) created a new paradigm for FHC based on finding enhanced motor function for R403Q alpha-MHC. To help resolve these conflicting mechanisms, we used a transgenic mouse model in which the endogenous alpha-MHC was largely replaced with transgenically encoded beta-MHC. A His(6) tag was cloned at the N terminus of the alpha-and beta-MHC to facilitate protein isolation by Ni(2+)-chelating chromatography. Characterization of the R403Q alpha-MHC by the in vitro motility assay showed a 30-40% increase in actin filament velocity compared with wild type, consistent with published studies. In contrast, the R403Q mutation in a beta-MHC backbone showed no enhancement in velocity. Cleavage of the His-tagged myosin by chymotrypsin made it possible to isolate homogeneous myosin subfragment 1 (S1), uncontaminated by endogenous myosin. We find that the actin-activated MgATPase activity for R403Q alpha-S1 is approximately 30% higher than for wild type, whereas the enzymatic activity for R403Q beta-S1 is reduced by approximately 10%. Thus, the functional consequences of the mutation are fundamentally changed depending upon the context of the cardiac MHC isoform.
AuthorsSusan Lowey, Leanne M Lesko, Arthur S Rovner, Alex R Hodges, Sheryl L White, Robert B Low, Mercedes Rincon, James Gulick, Jeffrey Robbins
JournalThe Journal of biological chemistry (J Biol Chem) Vol. 283 Issue 29 Pg. 20579-89 (Jul 18 2008) ISSN: 0021-9258 [Print] United States
PMID18480046 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Protein Isoforms
  • Propylthiouracil
  • Arginine
  • Ca(2+) Mg(2+)-ATPase
  • Ventricular Myosins
  • Myosin Heavy Chains
Topics
  • Animals
  • Arginine (genetics, metabolism)
  • Ca(2+) Mg(2+)-ATPase (metabolism)
  • Cardiomyopathy, Hypertrophic (genetics, metabolism)
  • Gene Expression Regulation (drug effects)
  • Mice
  • Mice, Transgenic
  • Models, Molecular
  • Mutation (genetics)
  • Myosin Heavy Chains (genetics, isolation & purification, metabolism)
  • Propylthiouracil (pharmacology)
  • Protein Isoforms (genetics, metabolism)
  • Protein Structure, Quaternary
  • Ventricular Myosins (genetics, isolation & purification, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: